Effet de l’acide tranexamique en injection locale dans l’arthroplastie totale de hanche chez les patients sous aspirine continue : une étude randomisée - 07/11/19
Effect of topical tranexamic acid in total hip arthroplasty patients who receive continuous aspirin for prevention of cardiovascular or cerebrovascular events: A prospective randomized study
Abstract |
Background |
Due to differences in pharmacological mechanism of action, the effect of tranexamic acid (TA) on aspirin-related bleeding remains unknown. We therefore conducted a prospective randomized study to elucidate (1) the effect of topical TA administration on blood loss and transfusion rate in total hip arthroplasty (THA) patients receiving continuous aspirin for prevention of cardiovascular or cerebrovascular events; (2) 90-day complications of topical TA administration; (3) possible variables contributing to blood transfusion.
Hypothesis |
Topical TA administration reduces blood loss and transfusion rate in THA patients receiving continuous aspirin.
Patients and methods |
A total of 102 consecutive THA patients taking continuous aspirin were enrolled and randomized into two groups. In the topical TA (TTA) group (n=55), topical TA was administered at three points during THA; in the control group (n=47), the patients received saline solution as placebo. Based on drop in hemoglobin concentration, total estimated blood loss was calculated as the main assessment criterion. Secondary assessment criteria included transfusion rate and 90-day complications. Finally, a multivariate regression model was used to assess possible predictive factors for blood transfusion.
Results |
(1) Significantly lower total blood loss was observed in the TTA group than in the control group (897±177ml vs. 1153±345ml, P<0.001). Furthermore, lower transfusion rate was observed in the TTA group than in the control group (34.0% vs. 10.9%, P=0.005). (2) No significant difference was observed between the two groups regarding 90-day complications. (3) We identified higher preoperative hemoglobin level (OR=0.675, P=0.002) and topical TA administration (OR=0.002, P=0.012) as negative predictive factors for blood transfusion.
Discussion |
Topical application of TA was safe and beneficial in THA patients receiving continuous aspirin for prevention of cardiovascular or cerebrovascular events, to reduce blood loss and transfusion rate, without increasing the risk of 90-day complications.
Le texte complet de cet article est disponible en PDF.Keywords : Tranexamic acid, Hip arthroplasty, Blood loss, Blood management, Complication
| ☆ | Cet article peut être consulté in extenso dans la version anglaise de la revue Orthopaedics & Traumatology: Surgery & Research sur Science Direct (sciencedirect.com) en utilisant le DOI ci-dessus. |
Vol 105 - N° 7
P. 868 - novembre 2019 Retour au numéro
Article précédent
- Résultats cliniques et dynamométriques de la réparation du système abducteur de hanche par plaque d’hydroxyapatite trochantérienne sur une prothèse modulaire après résection tumorale du fémur proximal
- Vincent Crenn, Sylvain Briand, Philippe Rosset, Jean-Camille Mattei, Alban Fouasson-Chailloux, Louis-Romée Le Nail, Denis Waast, Mickael Ropars, François Gouin
- Réduction sous contrôle arthroscopique des luxations postérieures de hanche causées par une rupture du mur périphérique du labrum: résultats cliniques et radiologiques à moyen terme
- Daohong Zhao, Hong Chen, Bo Zhao, Duo Shen, Zhaowei Jiang, Yuhao Zhang, Jun Zhang
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?